🇺🇸 Nebido in United States

190 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anxiety — 30 reports (15.79%)
  2. Nausea — 23 reports (12.11%)
  3. Fatigue — 21 reports (11.05%)
  4. Dyspnoea — 20 reports (10.53%)
  5. Paraesthesia — 20 reports (10.53%)
  6. Hypertension — 18 reports (9.47%)
  7. Asthenia — 15 reports (7.89%)
  8. Malaise — 15 reports (7.89%)
  9. Diarrhoea — 14 reports (7.37%)
  10. Headache — 14 reports (7.37%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Nebido approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Nebido in United States?

NU-Hospital Organization, Sweden is the originator. The local marketing authorisation holder may differ — check the official source linked above.